HeartSciences | Press Release Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indicative of diastolic function Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS;…
Jun 10, 2026 HeartSciences opens AI marketplace for heart care The company’s latest platform update brings FDA-cleared heart AI into everyday care and expands its recurring revenue strategy. Investors have…
June 2, 2026 Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ SaaS-based, recurring-revenue marketplace…
Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform Southlake, TX, May 19, 2026…
Welcome to The Beat | Issue 1Welcome to the inaugural edition of The BEAT from HeartSciences.Launching on May 11, 2026, The BEAT will offer timely insights, emerging trends, and perspectives shaping the future of…
May 5, 2026 Agreement with St. Vincent Health marks HeartSciences’ transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College…
